This observation aligns with previous studies demonstrating that TIM-3 expression is elevated on both CD4+ and CD8+ circulating T cells during the active chronic hepatitis phase, compared to other phases (30, 31). This evidence concerns the gene HAVCR2 and chronic hepatitis.